The global Blow-Fill-Seal (BFS) syringes market is poised to exceed a valuation of USD 878.48 million in 2023 and USD 2,158.46 million by 2033, with expectations to grow at a robust compound annual growth rate (CAGR) of 9.4% from 2023 to 2033. This growth trajectory is being driven by increasing demand across the healthcare and cosmetics sectors, along with a rising preference for advanced pharmaceutical packaging solutions.
According to a recent market study, the top three countries are projected to collectively account for approximately 35 to 40% of the BFS syringes market share in 2023. This signifies the growing regional prominence of BFS technology, which is extensively adopted for prefilled syringes, particularly in pharmaceutical applications.
See How Things Have Changed: Access the Old Source for This Report!
BFS technology offers several advantages, including high sterilization standards, cost-effectiveness, and precision, which are especially beneficial for the healthcare industry. The technology is rapidly gaining traction due to the preference for unit dose packaging and the increasing need for efficient pharmaceutical delivery systems.
BFS syringes are ideal for applications such as vaccines, injectables, and biologics, where maintaining sterility and accurate dosing is paramount.
In addition to the healthcare sector, BFS syringes are witnessing significant uptake in the cosmetics industry, especially for packaging serums and other skincare products. The precision and ease of use that BFS technology provides are fueling demand in this fast-growing market segment, further expanding the scope for BFS syringes.
Key Takeaways: BFS Syringes Market
- The global BFS syringes market grew at a CAGR of 8.7% from 2018 to 2022, reaching USD 803 million by the end of 2022.
- United States BFS syringe market is expected to create an incremental opportunity of USD 248 million between 2023 and 2033.
- India is projected to experience significant growth, with a CAGR of 10.9% from 2023 to 2033.
- Polypropylene (PE) is anticipated to generate a CAGR of 9.1% from 2023 to 2033.
- The pharmaceutical and healthcare sectors are projected to contribute more than USD 770 million in incremental opportunities by 2033 for the BFS syringes market.
Competitive Landscape
Key competitors in the BFS syringes market are pursuing various mergers and acquisitions to acquire a competitive advantage in the industry. They are also concentrating on new product launches and aseptic packaging to grow their consumer base.
Key players have partnered with pharmaceutical companies to provide contract manufacturing services for prefilled syringes, injectables, and ampoules. Capacity expansion, updating, augmenting output, and improving operational efficiency have all been key growth strategies for technology companies.
Recent Developments
- In March 2022, Gerresheimer a global leader in the packaging industry took over a new building in Ohio for filling medications with proper hygiene and aseptic packaging.
- In November 2021, Becton, Dickinson, and Company declared their investment in a new manufacturing facility in Spain which might help the company to increase its capacity for manufacturing pre-fillable syringes.
- In November 2017, Curida inked a contingency agreement with The Norwegian Armed Forces. This development is aimed at procuring a flexible hold on services and goods while maximizing the raw material prices.
- In May 2017, Weiler Engineering and Noxilizer came into an exclusive supply agreement for the BFS industry. Under this agreement, Noxilizer intends to deliver NOX FLEX Rapid Biodecontamination units for the latest ASEP-TECH Blow-Fil-Seal systems of Weiler Engineering, Inc. This development is projected to invigorate the company’s product line.
Market Key Players
IVEN Pharmatech Engineering Co., Ltd.; Brevetti Angela S.R.L; OPTIMA Packaging Group GmbH; Vanrx, AST, Inc; B. Braun Melsungen; Nipro; Takeda Pharmaceuticals International AG; Nephron Pharmaceuticals Corporation; Horizon Pharmaceutical Inc; Recipharm AB; Laboratorios SALVAT, S.A; The Ritedose Corporation; Unicep Packaging, LLC; Pharmapack Co. Ltd; Amanta Healthcare Ltd.; Automatic Liquid Packaging Solutions LLC; Asept Pak, Inc; SIFI Spa; Unither Pharmaceuticals SAS; LyondellBasell Industries N.V.
Global BFS Syringes Market by Category
By Capacity:
- 0.5-1 ml
- 1-3 ml
- Above 3 ml
By Material Type:
- Polypropylene (PP)
- Polyvinyl Chloride (PVC)
- Others (Polyethylene)
By End Use:
- Pharmaceuticals and Healthcare
- Personal Care and Cosmetics
- Others
By Region:
- North America
- Latin America
- Europe
- The Middle East and Africa
- East Asia
- South Asia
- Oceania
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
